牛牛AI助理已提取核心訊息
Richard R. DeLuca, EVP & President of Merck Animal Health, has completed a purchase of Merck & Co. common stock on January 22, 2024. The transaction involved the acquisition of 23,296 shares at a price of $119.43 per share. Following this transaction, DeLuca directly holds a total of 135,782.983 shares. Additionally, DeLuca has an indirect ownership of 1,230.1758 shares through a 401(k) plan. The total value of the shares acquired in the transaction is approximately $2.78 million.
Richard R. DeLuca, EVP & President of Merck Animal Health, has completed a purchase of Merck & Co. common stock on January 22, 2024. The transaction involved the acquisition of 23,296 shares at a price of $119.43 per share. Following this transaction, DeLuca directly holds a total of 135,782.983 shares. Additionally, DeLuca has an indirect ownership of 1,230.1758 shares through a 401(k) plan. The total value of the shares acquired in the transaction is approximately $2.78 million.
默沙東動物健康執行副總裁兼總裁理查德·德盧卡已於2024年1月22日完成對默沙東普通股的收購。該交易涉及以每股119.43美元的價格收購23,296股股票。在這筆交易之後，德盧卡直接持有總計135,782.983股股票。此外，德盧卡通過401（k）計劃間接擁有1,230.1758股股票的所有權。交易中收購的股票總價值約爲278萬美元。
默沙東動物健康執行副總裁兼總裁理查德·德盧卡已於2024年1月22日完成對默沙東普通股的收購。該交易涉及以每股119.43美元的價格收購23,296股股票。在這筆交易之後，德盧卡直接持有總計135,782.983股股票。此外，德盧卡通過401（k）計劃間接擁有1,230.1758股股票的所有權。交易中收購的股票總價值約爲278萬美元。
有用
沒用